Connect with us

Hi, what are you looking for?

Politics

California counties at trial argue J&J, other drugmakers fueled opioid epidemic

Politics15 minutes ago (Apr 19, 2021 02:56PM ET)

3/3
(C) Reuters. FILE PHOTO: A Teva Pharmaceutical Industries building is seen in Jerusalem

2/3

By Nate Raymond and Brendan Pierson

(Reuters) – Four drugmakers helped cause the deadly U.S. opioid epidemic and a “mountain” of pills to flood the country by deceptively marketing their drugs and downplaying their addictive risks, a lawyer for several California counties argued on Monday at the start of closely-watched trial.

Fidelma Fitzpatrick, the lawyer, told a California judge that Johnson & Johnson (NYSE:JNJ), Teva Pharmaceutical Industries (NYSE:TEVA) Ltd, Endo International (NASDAQ:ENDP) PLC and AbbVie (NYSE:ABBV)’s Allergan (NYSE:AGN) unit needed to be held responsible for a drug crisis that only got worse during the COVID-19 pandemic.

Her clients – the populous Santa Clara, Los Angeles and Orange counties and the city of Oakland – say those drugmakers should have to pay more than $50 billion to cover the costs of abating the public nuisance they created, plus penalties.

She told Orange County Superior Court Judge Peter Wilson that the case was about the companies’ “deadly legacy” of trying to boost their profits by promoting opioid painkillers to treat chronic pain while aware of the deadly consequences of doing so.

“The evidence will show each of these companies, all of them, knew what would happen: that their opioids would cause the crushing burden of addiction, overdose and death that California and its people have experienced,” Fitzpatrick said in her opening statement.

Lawyers for the companies are expected to deliver their own arguments later on Monday in the non-jury trial, which is being conducted virtually through Zoom due to the pandemic. The drugmakers argue they acted appropriately and that they did not cause the national opioid crisis.

Opioids have resulted in the overdose deaths of nearly 500,000 people from 1999 to 2019 in the United States, according to U.S. Centers for Disease Control and Prevention.

More than 3,300 similar lawsuits are pending nationally over the opioid crisis. The only other case to go to trial in the opioid litigation resulted in the state of Oklahoma in 2019 winning a $465 million judgment against J&J, which is appealing.

Other cases are slated to go to trial in the coming months, creating new pressure for the companies to reach settlements.

The nation’s three largest drug distributors – McKesson Corp (NYSE:MCK), AmerisourceBergen (NYSE:ABC) Corp and Cardinal Health Inc (NYSE:CAH) – and J&J have proposed paying a combined $26 billion to resolve the cases against them. The proposed deal has not been finalized.

California counties at trial argue J&J, other drugmakers fueled opioid epidemic

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Uncategorized

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt.

Uncategorized

Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione.

Uncategorized

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum.

Uncategorized

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora.

Disclaimer: Buzzclever.com it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Buzz Clever. All Rights Reserved